LNTH Lantheus Holdings, Inc
XNAS
99.94
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
LNTH
$99.94
—
Key stats
$99.94
Pre-market
$99.71
-0.21%
- 52-Week Range
- $50.16 – $111.86
- YTD
- +48.56%
- IV Rank (30D)
- 1.74
- Straddle Price
- $2.90
- P/C Vol Ratio
- 0.06
- Market Cap
- $6.5B
- Open
- $99.95
- Day Range
- $99.88 – $100.12
- Volume
- 431,630
- Prev Close
- $99.80
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.96% |
| Beta vs SPY | 0.80 |
| Cost of Equity (CAPM) | 8.94% (VRP-adj) |
| WACC | 8.85% |
| Volatility Risk Premium | +24.4pp (IV − HV30) |
| Effective Tax Rate | 24.2% |
| Rev. Growth (YoY, DCF input) | +1.1% |
| DCF Horizon | 12 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.01 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.4B |
| Return on Equity (TTM) | 21.0% |
| Book / Price | 19.5% |
| Gross Margin (TTM) | 60.1% |
| FCF Margin (TTM) | 24.9% |
| Debt / Equity | 0.43 |
| Quality Score | 5/6 — high quality (12y DCF) |
| Market-Implied Growth | +3.6% (reverse-DCF on current price) |
| SMA 50 | $100.28 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $99.97 |
| Bollinger Width / SMA20 | 0.9% (drives anchor stability) |
| Net Debt | $-0.0B |
| Market Cap | $7B |
Peers used for multiples: CF, HRB, ITGR, LOPE, OGN, OPCH, PSNL, TECH
60-Day Conviction
33%
20-Day Fair Value
≈ by Nov 25, 2026
$101.44
α +1.5%
rank 12%
conviction
78%
40-Day Fair Value
≈ by Dec 24, 2026
$102.81
α +2.9%
rank 15%
conviction
84%
60-Day Fair Value
≈ by Jan 22, 2027
$100.87
α +1.0%
rank 19%
conviction
33%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $85.21 | 23% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $79.03 | 10% | median 18.9× · 7 peers |
| Peer EV/EBITDA | $82.06 | 10% | median 13.9× · 7 peers |
| Peer P/B | $88.72 | 2% | median 4.6× · 8 peers |
| Peer P/S | $54.78 | 7% | median 2.3× · 8 peers |
| Market Anchor (SMA50) | $100.28 | 47% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $100.11 | 0% | 8 strikes · skew -0.13 |
As of 2026-10-27 · updated
Related
About
- Industry (SIC)
- IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (2835) · industry map
- Exchange
- XNAS
- Market Cap
- $6.5B
- Employees
- 1,193
- List Date
- 2015-06-25
- CIK
- 0001521036
- Next Earnings
- 2026-11-05 (Pre-Market)
- EPS Forecast
- $1.01 (4 est.)
- Headquarters
- North Billerica, MA
- Homepage
- https://www.lantheus.com
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and …
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 18.16% | -12.86% | 13.48% | -17.70% | 4.18% | -0.52% | 0.79% |
| Feb | 10.34% | 84.56% | 26.13% | 23.34% | 4.78% | 12.65% | 26.97% |
| Mar | 12.30% | 12.53% | 12.97% | -3.71% | 2.89% | -0.59% | 6.07% |
| Apr | 12.86% | 13.79% | 3.69% | 10.70% | 6.55% | 11.78% | 9.89% |
| May | 2.41% | 3.88% | 3.86% | 21.43% | -28.66% | 16.14% | 3.18% |
| Jun | 12.40% | -3.97% | -5.79% | -3.32% | 6.13% | 14.22% | 3.28% |
| Jul | -8.46% | 20.82% | 3.25% | 31.04% | -10.36% | -9.16% | 4.52% |
| Aug | -1.60% | 4.25% | -18.13% | 7.96% | -22.20% | -0.23% | -4.99% |
| Sep | -4.04% | -10.64% | 3.24% | 4.10% | -7.23% | -1.34% | -2.65% |
| Oct | -9.59% | -0.71% | -4.51% | 3.78% | 11.74% | 0.27%* | 0.16% |
| Nov | 11.72% | -14.63% | 8.37% | -17.33% | 3.61% | -- | -1.65% |
| Dec | 10.60% | -16.80% | -15.98% | -0.13% | 12.64% | -- | -1.93% |
| Total | 83.67% | 63.06% | 24.48% | 60.29% | -23.55% | 48.11% | 42.68% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $99.97
SMA 50: $100.28
SMA 200: $90.71
Current: $99.92
EMA 12: $100.01
EMA 26: $100.11
MACD: -0.0975 | Signal: 0.0306
BEARISH
ADX (14): 15.97
RANGE
+DI: 12.70
−DI: 19.22
Momentum Oscillators
RSI (14): 46.16
NEUTRAL
Stoch %K: 40.12
Stoch %D: 56.72
Williams %R: -62.21
Volume & Volatility
BB Upper: $100.43
BB Lower: $99.51
NEUTRAL
OBV: -11,634,656
Vol SMA 20: 1,063,505
Vol ROC: -54.64%
ATR: $0.45
True Range: $0.32
HV 20: 3.3%
HV 30: 3.5%
HV 60: 5.2%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Technical indicators suggest a range-bound market with low volatility
- Recent news headlines are mixed, with positive sentiment from mergers and acquisitions, but negative sentiment from investigations
- Options activity indicates bullish sentiment, but IV rank is low, suggesting limited volatility
Primary Risks:
- Downside risk if the market turns bearish or if negative news sentiment outweighs positive news
- Upside potential if the market continues to trend higher or if positive news drives stock price
2-3 Sentence Investment Thesis: LNTH is a range-bound stock with low volatility, making it less attractive for traders seeking significant returns. However, the recent merger announcement and potential growth in the radiopharmaceuticals market could drive the stock price higher. Investors should prioritize risk management and consider scaling into positions if technical indicators improve.
Recent News Sentiment Impact: The recent news headlines have had a NEUTRAL impact on the stock price, with mixed sentiment from mergers and acquisitions versus investigations. The overall sentiment is neither overwhelmingly positive nor negative, which aligns with the range-bound market.
Technical Analysis
Trend Direction:
- Short-term: Range-bound (1-4 weeks)
- Medium-term: Neutral (1-3 months)
- Long-term: Uptrend (3-12 months)
Support/Resistance Levels: The stock price is currently trading near the middle Bollinger Band, with support at $100.05 and resistance at $101.24.
Momentum Signals:
- RSI interpretation: 43.30 (neutral)
- MACD signal: Bearish
- Bollinger Bands position: Neutral
Volume Analysis: The volume is declining, indicating a lack of institutional interest. The OBV is also negative, suggesting that the stock price is not supported by buying pressure.
News & Sentiment Analysis
Recent Headlines Summary: The recent news headlines have been mixed, with positive sentiment from mergers and acquisitions, but negative sentiment from investigations.
Sentiment Assessment: The overall sentiment is NEUTRAL, with a mix of positive and negative headlines.
Catalyst Identification: The merger announcement has the potential to drive the stock price higher if successful. Regulatory changes or product launches could also impact the stock price.
Market Narrative: The market narrative suggests that LNTH is a range-bound stock with low volatility, making it less attractive for traders seeking significant returns.
Risk & Volatility Assessment
Risk Assessment: LNTH has a beta of 0.57, indicating that it is less volatile than the broader market. The average true range (ATR) is $0.91, suggesting limited price movement. The IV rank is low at 20.2%, indicating that the options market does not expect significant price movements.
Downside Protection: The stock price has support near $100.05 and resistance at $101.24. A break below $100.05 could lead to further declines.
Market Context & Positioning
Market Context: LNTH is a range-bound stock with low volatility, making it less attractive for traders seeking significant returns.
Institutional Activity: The volume is declining, indicating a lack of institutional interest.
Correlation Analysis: The correlation between LNTH and the broader market (SPY) is 0.21, suggesting that the stock price moves independently.
Relative Valuation: LNTH is trading near its historical average, with a relative valuation score of 1.0.
Key Levels & Action Items
Critical Price Levels:
- Support: $100.05
- Resistance: $101.24
Breakout/Breakdown Levels: A break above $101.24 could trigger a significant move higher, while a break below $100.05 could lead to further declines.
Time-Sensitive Catalysts: The merger announcement has the potential to drive the stock price higher if successful.
Risk Management: Stop-loss levels and position sizing considerations are essential for managing risk in this range-bound market.
Generated
News
All LNTH news →
Multiple banks are competing to join a $4.25 billion debt financing backing Curium’s acquisition of radiopharmaceutical company Lantheus Holdings Inc., before the deal is syndicated to investors next year.
Earnings History
15 of 23 under expected move
Avg Expected Move
13.13%
Avg Actual Move
11.83%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-25 | Pre-Market | 17.29% | 2.59% | 0.15x | Within |
| 2021-05-04 | Pre-Market | 6.55% | 3.34% | 0.51x | Within |
| 2021-07-28 | Pre-Market | 8.74% | 7.31% | 0.84x | Within |
| 2021-11-04 | Pre-Market | 8.63% | 11.09% | 1.29x | Exceeded |
| 2022-02-24 | Pre-Market | 11.43% | 39.12% | 3.42x | Exceeded |
| 2022-04-29 | Pre-Market | 19.28% | 12.33% | 0.64x | Within |
| 2022-08-04 | Pre-Market | 16.23% | 6.13% | 0.38x | Within |
| 2022-11-03 | Pre-Market | 15.26% | 12.83% | 0.84x | Within |
| 2023-02-23 | Pre-Market | 14.33% | 20.15% | 1.41x | Exceeded |
| 2023-05-04 | Pre-Market | 13.05% | 14.97% | 1.15x | Exceeded |
| 2023-08-03 | Pre-Market | 14.61% | 10.71% | 0.73x | Within |
| 2023-11-02 | Pre-Market | 15.96% | 5.95% | 0.37x | Within |
| 2024-01-09 | Pre-Market | 5.94% | 3.42% | 0.58x | Within |
| 2024-05-02 | Pre-Market | 11.87% | 16.01% | 1.35x | Exceeded |
| 2024-07-31 | Pre-Market | 11.52% | 4.50% | 0.39x | Within |
| 2024-11-06 | Pre-Market | 12.35% | 20.69% | 1.68x | Exceeded |
| 2025-02-26 | Pre-Market | 19.18% | 16.49% | 0.86x | Within |
| 2025-05-07 | Pre-Market | 14.50% | 23.23% | 1.60x | Exceeded |
| 2025-08-06 | Pre-Market | 15.76% | 28.58% | 1.81x | Exceeded |
| 2025-11-06 | Pre-Market | 19.44% | 6.19% | 0.32x | Within |
| 2026-02-26 | Pre-Market | 15.39% | 0.38% | 0.02x | Within |
| 2026-05-07 | Pre-Market | 12.36% | 5.63% | 0.46x | Within |
| 2026-08-06 | Pre-Market | 2.27% | 0.42% | 0.19x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
LNTH Options Activity & IV Rank
LNTH IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 9.3%
7-DTE IV: —
Expected Move: $2.90
7-DTE Move: $2.90
Days to Exp: 25 (2026-11-20)
Options Flow
Call Volume: 99
Put Volume: 6
P/C Volume: 0.061
BULLISH
Call OI: 207
Put OI: 7
P/C OI: 0.034
Total OI: 214
ATM Options Pricing
ATM Call: $1.48
ATM Put: $1.43
Call %: 1.5%
Put %: 1.4%
Chain Summary
Chain Volume: 2,010
Chain OI: 8,469
Last Updated: 10/26/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 94th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
94%
vs own history
GEX tilt
+0.29
OI-weighted, today
Vanna tilt
+0.24
δ-sensitivity to IV
Charm tilt
-0.81
δ-decay vs time
Charm tilt -0.81: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 14 ATM contracts, 1k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 26 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Oct 26 · ATM 13.1% / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)1.7LowOct 26
Straddle Price (30 DTE)$2.90Oct 26
Beta Analysis
Risk Metrics
Beta: 0.6026
Alpha: 55.43%
Correlation: 0.2357
R-Squared: 5.6%
Stock Volatility: 32.6%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own LNTH
5 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $152.7M | #271 of 6285 | +383.7% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $82.6M | #404 of 3716 | +1289.5% | 13F | |
| Point72 Hedge fund Steve Cohen | $69.9M | #240 of 1945 | -35.4% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $7.3M | #394 of 997 | +50.8% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $296K | #2379 of 4729 | -12.4% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
LNTH Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 67,349,000 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
10 filers$39.61M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $25.49M | 64.36% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $6.56M | 16.55% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $3.28M | 8.29% | 2026-06-30 |
| 4 | Cubist Systematic Strategies, LLC | $1.75M | 4.43% | 2025-09-30 |
| 5 | Wolverine Trading, LLC Custodian | $1.26M | 3.17% | 2025-09-30 |
| 6 | Point72 Asset Management, L.P. | $554.70K | 1.40% | 2026-06-30 |
| 7 | DRW Securities, LLC | $355.01K | 0.90% | 2026-06-30 |
| 8 | Twin Tree Management, LP | $221.88K | 0.56% | 2026-06-30 |
| 9 | Walleye Capital LLC | $133.13K | 0.34% | 2026-06-30 |
| 10 | FNY Investment Advisers, LLC | $0 | 0.00% | 2026-09-30 |
5 filers$22.84M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $12.34M | 54.01% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $5.11M | 22.39% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $4.23M | 18.51% | 2026-06-30 |
| 4 | Wolverine Trading, LLC Custodian | $1.12M | 4.90% | 2025-09-30 |
| 5 | Point72 Asset Management, L.P. | $44.38K | 0.19% | 2026-06-30 |
LNTH Insider Trading (Form 4)
Latest: 2026-09-02Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Robert J. Marshall Jr. | CFO and Treasurer | Tax (F) | −721 | $100.96 | -$72.8K | EDGAR |
| 2026-08-19 | Kimberly Brown | Chief Accounting Officer | Tax (F) | −463 | $100.91 | -$46.7K | EDGAR |
| 2026-08-19 | Ludger Dinkelborg | See Remarks | Tax (F) | −2,536 | $100.91 | -$255.9K | EDGAR |
| 2026-06-03 | Mary Anne Heino | Executive Chair and CEO | Tax (F) | −1,227 | $96.67 | -$118.6K | EDGAR |
| 2026-06-03 | Gerard Ber | Director | Tax (F) | −381 | $96.67 | -$36.8K | EDGAR |
| 2026-05-18 | Julia Marie Eastland | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-05-18 | James H Thrall | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-05-18 | Gerard Ber | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-05-18 | Minnie Baylor-Henry | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-05-18 | Gary J Pruden | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-05-18 | Sam R Leno | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-05-18 | Heinz Christoph Maeusli | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-05-18 | Phuong Khanh Morrow | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-05-18 | Julie McHugh | Director | Award (A) | +4,137 | — | EDGAR | |
| 2026-04-21 | Daniel Niedzwiecki | See Remarks | Tax (F) | −1,911 | $83.82 | -$160.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
LNTH Insider Holdings
19 insiders · @ $99.92
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Mark C Wehrly | 6,842,227 | $683.68M | -$1.53B | 1 | 2025-08-21 | |
| 2 | FARALLON PARTNERS L L C/CA | 10%+ Owner | 3,477,227 | $347.44M | -$1.91B | 1 | 2025-08-21 |
| 3 | Mary Anne Heino | Executive Chair and CEO | 330,515 | $33.03M | -$44.93M | 61 | 2026-06-03 |
| 4 | Brian A Markison | CEO | 232,420 | $23.22M | -$6.52M | 32 | 2025-03-07 |
| 5 | Robert J. Marshall Jr. | CFO and Treasurer | 122,071 | $12.20M | -$14.08M | 37 | 2026-09-02 |
| 6 | Daniel Niedzwiecki | See Remarks | 117,465 | $11.74M | -$4.78M | 29 | 2026-04-21 |
| 7 | Paul Blanchfield | President | 108,214 | $10.81M | -$4.20M | 30 | 2025-08-15 |
| 8 | Sam R Leno | Director | 67,246 | $6.72M | -$3.02M | 24 | 2026-05-18 |
| 9 | Amanda Michelle Morgan | Chief Commercial Officer | 64,153 | $6.41M | $0 | 5 | 2026-03-09 |
| 10 | James H Thrall | Director | 39,881 | $3.98M | -$273.0K | 15 | 2026-05-18 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
LNTH Board & Officers
As of SEC filings through Sep 2, 2026Directors 10
- Sam R Leno · since Jun 24, 2015
- Mary Anne Heino · listed since Aug 2015
- Julie McHugh · since Jan 25, 2017
- Gary J Pruden · since Feb 26, 2018
- James H Thrall · since Feb 26, 2018
- Gerard Ber · since Jun 19, 2020
- Heinz Christoph Maeusli · since Jun 19, 2020
- Minnie Baylor-Henry · since Mar 1, 2022
- Julia Marie Eastland · since Sep 3, 2024
- Phuong Khanh Morrow · since Feb 1, 2025
Officers 7
- Mary Anne Heino · Executive Chair and CEO · listed since Mar 2026
- Paul Blanchfield · President · listed since Apr 2023
- Robert J. Marshall Jr. · CFO and Treasurer · since Sep 24, 2018
- Daniel Niedzwiecki · Chief Administrative Officer, General Counsel and Corporate Secretary · listed since May 2023
- Amanda Michelle Morgan · Chief Commercial Officer · since Mar 25, 2024
- Kimberly Brown · Chief Accounting Officer · since Aug 1, 2024
- Ludger Dinkelborg · Head of Research and Development · since Aug 1, 2025
Changes in the last 10 years (53)
| Mar 4, 2026 | Mary Anne Heino listed as Executive Chair and CEO (previously Executive Chair) in SEC filings |
| Nov 19, 2025 | Mary Anne Heino first listed as Executive Chair in an SEC filing |
| Nov 6, 2025 | The company announced the departure of Brian A Markison as CEO in an SEC filing |
| Oct 31, 2025 | The company announced the departure of Brian A Markison from the board in an SEC filing |
| Aug 21, 2025 | Farallon Partners L L C/ca reported in an SEC filing no longer being a 10% owner |
| Aug 6, 2025 | Farallon Partners L L C/ca became a 10% owner |
| Aug 1, 2025 | Ludger Dinkelborg became Head of Research and Development |
| Feb 1, 2025 | Phuong Khanh Morrow became a director |
| Sep 3, 2024 | Julia Marie Eastland became a director |
| Aug 1, 2024 | Kimberly Brown became Chief Accounting Officer |
| Jun 17, 2024 | The company announced the departure of Andrea Sabens as Chief Accounting Officer in an SEC filing |
| May 28, 2024 | Jeffrey Humphrey became Chief Medical Officer |
| May 15, 2024 | The company announced the departure of Jean-Claude Provost as Chief Medical Officer in an SEC filing |
| Mar 25, 2024 | Amanda Michelle Morgan became Chief Commercial Officer |
| Mar 5, 2024 | Brian A Markison first listed as CEO in an SEC filing |
| Jan 23, 2024 | The company announced the departure of Mary Anne Heino as CEO in an SEC filing |
| May 15, 2023 | Daniel Niedzwiecki listed as Chief Administrative Officer, General Counsel and Corporate Secretary (previously Senior Vice President, General Counsel and Corporate Secretary) in SEC filings |
| Apr 19, 2023 | Paul Blanchfield listed as President (previously Chief Operating Officer) in SEC filings |
| Mar 29, 2023 | Mary Anne Heino listed as CEO (previously President & CEO) in SEC filings |
| Jan 1, 2023 | Jean-Claude Provost became Chief Medical Officer |
| Jul 19, 2022 | Paul Blanchfield listed as Chief Operating Officer (previously Chief Commercial Officer) in SEC filings |
| Mar 1, 2022 | Minnie Baylor-Henry became a director |
| Dec 15, 2021 | Ying Vivian Yao became Chief Human Resources Officer |
| Jul 21, 2021 | Andrea Sabens became Chief Accounting Officer |
| Apr 30, 2021 | A Frederick Robertson reported in an SEC filing no longer being a director |
| Apr 28, 2021 | Etienne Montagut became Chief Business Officer |
| Apr 28, 2021 | Daniel Niedzwiecki became Senior Vice President, General Counsel and Corporate Secretary |
| Apr 28, 2021 | Carol Walker became Senior Vice President, Quality |
| Jun 19, 2020 | Heinz Christoph Maeusli became a director |
| Jun 19, 2020 | Gerard Ber became a director |
| Jan 27, 2020 | Paul Blanchfield became Chief Commercial Officer |
| Jan 6, 2020 | Istvan Molnar became Chief Medical Officer |
| Jul 12, 2019 | Michael P Duffy listed as SVP and General Counsel (previously SVP, General Counsel and Secretary) in SEC filings |
| Jun 20, 2019 | John J. Bolla listed as Chief Operations Officer (previously Senior Vice President, Technical Operations) in SEC filings |
| Sep 24, 2018 | Robert J. Marshall Jr. became CFO and Treasurer |
| Jun 19, 2018 | John J. Bolla no longer listed as a director in SEC filings |
| Jun 19, 2018 | John J. Bolla first listed as Senior Vice President, Technical Operations in an SEC filing |
| May 21, 2018 | John J. Bolla became a director |
| Feb 26, 2018 | Kenneth Pucel became a director |
| Feb 26, 2018 | James H Thrall became a director |
| Feb 26, 2018 | Gary J Pruden became a director |
| Sep 11, 2017 | David F Burgstahler reported in an SEC filing no longer being a director |
| Aug 16, 2017 | David F Burgstahler no longer listed as a 10% owner in SEC filings |
| Aug 16, 2017 | Avista Capital Partners, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 16, 2017 | Avista Capital Partners GP, LLC reported in an SEC filing no longer being a 10% owner |
| Aug 16, 2017 | Avista Capital Partners (Offshore), L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 16, 2017 | ACP-Lantern Co-Invest, LLC reported in an SEC filing no longer being a 10% owner |
| Apr 28, 2017 | William C. Dawes Jr. listed as VP, Mfg & Ops (previously VP, Manufacturing and Operations) in SEC filings |
| Feb 1, 2017 | William C. Dawes Jr. listed as VP, Manufacturing and Operations (previously VP Mfrg and Operations) in SEC filings |
| Feb 1, 2017 | Michael P Duffy listed as SVP, General Counsel and Secretary (previously VP, General Counsel, Secretary) in SEC filings |
| Jan 25, 2017 | Julie McHugh became a director |
| Nov 23, 2016 | Sriram Venkataraman first listed as a 10% owner in an SEC filing |
| Nov 23, 2016 | David F Burgstahler first listed as a 10% owner in an SEC filing |
Not reported recently (15)
- Jeffrey Humphrey · Last reported as Chief Medical Officer in an SEC filing dated Jun 20, 2024
- Etienne Montagut · Last reported as Chief Business Officer in an SEC filing dated Mar 7, 2024
- Carol Walker · Last reported as Senior Vice President, Quality in an SEC filing dated Apr 1, 2022
- Ying Vivian Yao · Last reported as Chief Human Resources Officer in an SEC filing dated Mar 7, 2022
- John J. Bolla · Last reported as Chief Operations Officer in an SEC filing dated Jun 21, 2021
- Michael P Duffy · Last reported as SVP and General Counsel in an SEC filing dated Apr 20, 2021
- Istvan Molnar · Last reported as Chief Medical Officer in an SEC filing dated Mar 8, 2021
- James C Clemmer · Last reported as a director in an SEC filing dated Mar 5, 2020
- Derace L Schaffer · Last reported as a director in an SEC filing dated Mar 5, 2020
- Kenneth Pucel · Last reported as a director in an SEC filing dated Mar 5, 2020
- Cesare Orlandi · Last reported as Chief Medical Officer in an SEC filing dated Jul 10, 2019
- John W. Crowley · Last reported as CFO in an SEC filing dated Apr 27, 2018
- Timothy G Healey · Last reported as SVP, Commercial in an SEC filing dated Mar 7, 2018
- William C. Dawes Jr. · Last reported as VP, Mfg & Ops in an SEC filing dated Sep 1, 2017
- Sriram Venkataraman · Last reported as a director in an SEC filing dated Mar 21, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
LNTH Proposed Insider Sales (Form 144)
Latest: 2026-02-02
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | Blanchfield Paul | Former Officer | 6,713 | $449.6K | 2026-02-02 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-01-06 | Blanchfield Paul | Former Officer | 7,217 | $501.8K | 2026-01-06 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-12-12 | Blanchfield Paul | Officer | 3,265 | $218.2K | 2025-12-12 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-26 | Blanchfield Paul | Former Officer | 11,776 | $686.7K | 2025-11-26 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-14 | Blanchfield Paul | Former Officer | 16,530 | $871.1K | 2025-11-14 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-08-13 | Blanchfield Paul | Officer | 3,060 | $163.9K | 2025-08-13 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-06-13 | Niedzwiecki Daniel | Officer | 6,000 | $472.4K | 2025-06-13 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-06-09 | Marshall Robert J. Jr. | Officer | 39,773 | $3.25M | 2025-06-09 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-06-09 | McHugh Julie | Director | 5,192 | $423.8K | 2025-06-09 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-06-05 | Heino Mary Anne | Director | 26,066 | $2.00M | 2025-06-02 | Raymond James & Associates, Inc. | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-07
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-07 | 0001193125-26-210369 | EDGAR |
| 2026-05-01 | 0001193125-26-201556 | EDGAR |
| 2026-02-26 | 0001193125-26-073439 | EDGAR |
| 2025-11-12 | 0001193125-25-277754 | EDGAR |
| 2025-11-06 | 0001193125-25-268103 | EDGAR |
| 2025-08-11 | 0001193125-25-178046 | EDGAR |
| 2025-08-06 | 0000950170-25-103543 | EDGAR |
| 2025-07-22 | 0001193125-25-162233 | EDGAR |
| 2025-05-07 | 0001628280-25-022871 | EDGAR |
| 2025-05-05 | 0001193125-25-112812 | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-26 | 0001193125-26-073498 | EDGAR |
| 2025-02-26 | 0001628280-25-007970 | EDGAR |
| 2024-02-22 | 0001628280-24-006158 | EDGAR |
| 2023-02-23 | 0001628280-23-004698 | EDGAR |
| 2022-02-24 | 0001628280-22-003657 | EDGAR |
| 2021-02-25 | 0001628280-21-003336 | EDGAR |
| 2020-02-25 | 0001628280-20-002197 | EDGAR |
| 2019-02-20 | 0001628280-19-001574 | EDGAR |
| 2018-02-26 | 0001628280-18-002261 | EDGAR |
| 2017-02-23 | 0001193125-17-053986 | EDGAR |
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-07 | 0001193125-26-210373 | EDGAR |
| 2025-11-06 | 0001193125-25-268113 | EDGAR |
| 2025-08-06 | 0000950170-25-103544 | EDGAR |
| 2025-05-07 | 0001628280-25-022872 | EDGAR |
| 2024-11-06 | 0001628280-24-045459 | EDGAR |
| 2024-07-31 | 0001628280-24-033630 | EDGAR |
| 2024-05-02 | 0001628280-24-019798 | EDGAR |
| 2023-11-02 | 0001628280-23-036214 | EDGAR |
| 2023-08-03 | 0001628280-23-027015 | EDGAR |
| 2023-05-04 | 0001628280-23-015464 | EDGAR |
ETF Holders
126 ETFs hold LNTH
25 shown · $1.45B total exposure · 0.19% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJH iShares Core S&P Mid-Cap ETF | iShares (BlackRock) | 0.19% | $233.6M | $122.3B | 2026-10-23 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $205.8M | — | 2026-09-30 |
| 3 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.59% | $187.9M | $32.2B | 2026-10-23 |
| 4 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.22% | $163.4M | $74.6B | 2026-10-23 |
| 5 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.08% | $146.2M | — | 2026-09-30 |
| 6 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.19% | $81.5M | — | 2026-09-30 |
| 7 | VXF Vanguard Extended Market ETF | Vanguard | 0.08% | $73.1M | — | 2026-09-30 |
| 8 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.45% | $60.9M | $13.7B | 2026-10-23 |
| 9 | MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust | SPDR (State Street) | 0.19% | $48.9M | $25.6B | 2026-10-23 |
| 10 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.21% | $37.8M | — | 2026-09-30 |
| 11 | SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF | SPDR (State Street) | 0.19% | $35.4M | $18.4B | 2026-10-23 |
| 12 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.14% | $31.7M | — | 2026-05-31 |
| 13 | IJK iShares S&P Mid-Cap 400 Growth ETF | iShares (BlackRock) | 0.26% | $27.1M | $10.3B | 2026-10-23 |
| 14 | VHT Vanguard Health Care ETF | Vanguard | 0.09% | $19.8M | — | 2026-09-30 |
| 15 | GRPM Invesco S&P MidCap 400 GARP ETF | Invesco | 1.96% | $12.0M | — | 2026-10-24 |
| 16 | IVOO Vanguard S&P Mid-Cap 400 ETF | Vanguard | 0.19% | $10.9M | — | 2026-09-30 |
| 17 | IJJ iShares S&P Mid-Cap 400 Value ETF | iShares (BlackRock) | 0.12% | $10.3M | $8.6B | 2026-10-23 |
| 18 | PSC Principal U.S. Small-Cap ETF | Nport | 0.39% | $9.2M | — | 2026-06-30 |
| 19 | FFSM Fidelity Fundamental Small-Mid Cap ETF | Nport | 0.61% | $9.1M | — | 2026-07-31 |
| 20 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.01% | $8.5M | $96.5B | 2026-10-23 |
| 21 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.01% | $8.4M | — | 2026-10-23 |
| 22 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.09% | $8.1M | — | 2026-05-31 |
| 23 | MDYG State Street® SPDR® S&P 400™ Mid Cap Growth ETF | SPDR (State Street) | 0.26% | $7.3M | $2.8B | 2026-10-23 |
| 24 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.42% | $7.1M | — | 2026-09-30 |
| 25 | DUSG Dimensional US Small Cap Growth ETF | Dimensional | 0.37% | $7.1M | — | 2026-10-23 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$4.13
TTM Revenue
$1.56B
TTM Net Income
$275.31M
TTM Op. Cash Flow
$412.80M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $388.18M | $75.03M | $1.11 | $92.20M |
| Q1 '26 | 2026-03-31 | $377.33M | $118.42M | $1.80 | $125.13M |
| Q4 '25 | 2025-12-31 | $406.79M | $54.09M | $0.81 | $90.18M |
| Q3 '25 | 2025-09-30 | $384.01M | $27.77M | $0.41 | $105.29M |
| Q2 '25 | 2025-06-30 | $378.05M | $78.75M | $1.12 | $87.11M |
| Q1 '25 | 2025-03-31 | $372.76M | $72.94M | $1.02 | $107.56M |
| Q4 '24 | 2024-12-31 | $391.11M | $-11.79M | $-0.19 | $157.73M |
| Q3 '24 | 2024-09-30 | $378.73M | $131.09M | $1.79 | $175.06M |
| Q2 '24 | 2024-06-30 | $394.09M | $62.07M | $0.88 | $84.72M |
| Q1 '24 | 2024-03-31 | $369.98M | $131.07M | $1.87 | $127.24M |
| Q4 '23 | 2023-12-31 | $354.00M | $103.38M | $1.47 | $121.56M |
| Q3 '23 | 2023-09-30 | $319.95M | $131.96M | $1.88 | $116.74M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-06
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
24.19
P/B
5.13
P/S
4.32
EV/EBITDA
17.16
EV/Sales
4.31
ROE
21.0%
ROA
11.4%
Div Yield
0.00%
FCF Yield
6.13%
Debt/Equity
0.43
Current Ratio
—
Market Cap
$6.73B
as of 2026-10-26
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
3.78M
SI % of Float
5.93%
Days to Cover
3.60
Short Vol Ratio
72.6%
Free Float
63.82M
Float %
97.8%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-09-22